Potential Role of Decoy B7-H4 in the Pathogenesis of Rheumatoid Arthritis: A Mouse Model Informed by Clinical Data

Finding an association between soluble B7-H4 and rheumatoid arthritis severity, Lieping Chen and colleagues use a mouse model to show that the soluble form blocks the inhibitory function of cell-surface B7-H4.

[1]  G. Zhu,et al.  B7-H4-deficient mice display augmented neutrophil-mediated innate immunity. , 2009, Blood.

[2]  M. Norman,et al.  A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. , 2008, Blood.

[3]  C. Nielsen,et al.  Comment on “Aberrant Regulation of Synovial T Cell Activation by Soluble Costimulatory Molecules in Rheumatoid Arthritis” , 2007, The Journal of Immunology.

[4]  M. Jordana,et al.  Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice , 2006, Molecular and Cellular Biology.

[5]  A. Roberts,et al.  Granulocyte colony-stimulating factor and neutrophils—forgotten mediators of inflammatory disease , 2006, Nature Clinical Practice Rheumatology.

[6]  Gefeng Zhu,et al.  B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma , 2006, The Journal of experimental medicine.

[7]  E. Diamandis,et al.  B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. , 2006, Cancer research.

[8]  T. Geijtenbeek,et al.  Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN , 2005, The Journal of experimental medicine.

[9]  A. Sharpe,et al.  The B7/CD28 costimulatory family in autoimmunity , 2005, Immunological reviews.

[10]  M. Lucia,et al.  B7-H4 Is Highly Expressed in Ductal and Lobular Breast Cancer , 2005, Clinical Cancer Research.

[11]  D. Vignali,et al.  Biochemical Analysis of the Regulatory T Cell Protein Lymphocyte Activation Gene-3 (LAG-3; CD223)1 , 2004, The Journal of Immunology.

[12]  V. Blaho,et al.  Treatment of Mice with the Neutrophil-Depleting Antibody RB6-8C5 Results in Early Development of Experimental Lyme Arthritis via the Recruitment of Gr-1− Polymorphonuclear Leukocyte-Like Cells , 2004, Infection and Immunity.

[13]  Lieping Chen.  Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity , 2004, Nature Reviews Immunology.

[14]  Satyajit Mayor,et al.  Sorting GPI-anchored proteins , 2004, Nature Reviews Molecular Cell Biology.

[15]  P. Kubes,et al.  Essential Role for Neutrophil Recruitment to the Liver in Concanavalin A-Induced Hepatitis 1 , 2004, The Journal of Immunology.

[16]  Kutty Selva Nandakumar,et al.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. , 2003, The American journal of pathology.

[17]  R. Scheule,et al.  Hydrodynamic delivery of DNA , 2003, Expert opinion on biological therapy.

[18]  P. Loke,et al.  B7x: A widely expressed B7 family member that inhibits T cell activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Zhu,et al.  B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. , 2003, Immunity.

[20]  C. Dong,et al.  B7S1, a novel B7 family member that negatively regulates T cell activation. , 2003, Immunity.

[21]  G. Zhu,et al.  Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. , 2003, The Journal of clinical investigation.

[22]  M. Gunn,et al.  Cd11c+B220+Gr-1+ Cells in Mouse Lymph Nodes and Spleen Display Characteristics of Plasmacytoid Dendritic Cells , 2001, The Journal of experimental medicine.

[23]  Paul M. Allen,et al.  Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis1 , 2001, The Journal of Immunology.

[24]  G. Zhu,et al.  B7-H3: A costimulatory molecule for T cell activation and IFN-γ production , 2001, Nature Immunology.

[25]  G. Zhu,et al.  B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. , 2001, Nature immunology.

[26]  K. Eguchi,et al.  High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis. , 2000, Clinical and experimental rheumatology.

[27]  F. Bazzoni,et al.  The neutrophil as a cellular source of chemokines , 2000, Immunological reviews.

[28]  J. Bonnefoy,et al.  Soluble CD86 is a costimulatory molecule for human T lymphocytes. , 2000, Immunity.

[29]  J. Salinas,et al.  Polymorphonuclear Neutrophils Are Necessary for the Recruitment of CD8+ T Cells in the Liver in a Pregnant Mouse Model of Chlamydophila abortus (Chlamydia psittaci Serotype 1) Infection , 2000, Infection and Immunity.

[30]  G. Zhu,et al.  Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules. , 2000, Methods in molecular medicine.

[31]  M. Burdick,et al.  The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. , 1999, Journal of immunology.

[32]  T. Mak,et al.  CD28-deficient mice are highly resistant to collagen-induced arthritis. , 1999, Journal of immunology.

[33]  S. McColl,et al.  Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[34]  P. Ward,et al.  Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. , 1997, Journal of immunology.

[35]  E. Tindall,et al.  Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.

[36]  S. Edwards,et al.  Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. , 1997, Immunology today.

[37]  P. Hutchinson,et al.  Anti‐neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis , 1997, Clinical and experimental immunology.

[38]  R. Pinals,et al.  Leukocytosis in Rheumatoid Arthritis , 1996, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[39]  M. Prevoo,et al.  Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. , 1996, Arthritis and rheumatism.

[40]  A. Matsukawa,et al.  Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. , 1995, Cellular immunology.

[41]  S. Abramson,et al.  The neutrophil in rheumatoid arthritis. , 1995, Rheumatic diseases clinics of North America.

[42]  M. Cassatella.  The production of cytokines by polymorphonuclear neutrophils. , 1995, Immunology today.

[43]  M. Feldmann,et al.  Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Fava,et al.  Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen‐arthritis , 1993, Clinical and experimental immunology.

[45]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[46]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[47]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[48]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.